Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | THAP8 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
mRNA | RP1-309K20.6 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
mRNA | SMARCC1 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
mRNA | RP11-529K1.3 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
mRNA | FGF17 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
mRNA | EHMT1 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
mRNA | TMOD4 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
mRNA | GRK2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
mRNA | CPXM2 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
mRNA | ADAM23 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |